Jolene Chandra’s Post

Unlocking access to essential diagnostics, Axios International empowers patients worldwide through comprehensive educational campaigns and targeted outreach efforts. One significant initiative includes disease awareness campaigns to educate the public, patients, caregivers, and healthcare providers about various conditions, symptoms, risk factors, and available treatments. These efforts promote early detection, exemplified by our breast cancer awareness campaign in India, which encouraged self-examination and mammography. We facilitated screening and referrals, ensuring timely diagnosis and treatment initiation for confirmed cases. Moreover, we engage in personalized outreach to understand individual patient needs, developing tailored educational plans that empower informed healthcare decisions. For instance, one of our partnerships with an insurance company in Thailand promoted early prostate cancer screening by eliminating financial barriers, enhancing access to critical diagnostics services and potentially improving patient health outcomes. To learn more about our access to diagnosis solutions, visit https://lnkd.in/dCH627gr #AccesstoDiagnosis #PatientsFirst #EarlyDetection #Healthcheckups

India's diagnostic sector is vital for disease detection, treatment planning, and patient monitoring. Driven by a large population, rising disease burden, and a shift toward preventive care, it plays a key role in improving health outcomes. This article examines its current status, challenges, and future prospects.More... Dr Lalpath Labs, Agilus Diagnostics,Metropolis Healthcare,Thyrocare Technologies Ltd. Ameera Shah, https://lnkd.in/ggef2yJK

World Scleroderma Day: new treatments in development hold promise for patients, says GlobalData - https://bit.ly/3xGQ5sW | #chronic_autoimmune_connective_tissue_disorder #Scleroderma #World_Scleroderma_Day

While innovative treatments have the potential to improve healthcare and outcomes, many health systems are struggling to keep pace with capacity and the roll-out of new practices and procedures. ‘Health system readiness’ refers to a health system's ability to adapt to and integrate effective new approaches to care. Building on our extensive programme of work on health system readiness and radioligand therapy – an innovative approach to treating certain types of cancer – we have developed a set of key performance indicators (KPIs) that can serve as targets for countries looking to integrate radioligand therapy. These indicators were developed based on our inaugural Radioligand Therapy Readiness Assessment Framework, with input from expert advisors. Explore the KPIs and learn more about implementation frameworks and the growing potential of radioligand therapy: https://lnkd.in/eZc9aM5b

𝐄𝐦𝐩𝐨𝐰𝐞𝐫𝐢𝐧𝐠 𝐏𝐚𝐭𝐢𝐞𝐧𝐭𝐬 𝐓𝐡𝐫𝐨𝐮𝐠𝐡 𝐏𝐞𝐫𝐬𝐨𝐧-𝐂𝐞𝐧𝐭𝐞𝐫𝐞𝐝 𝐂𝐚𝐫𝐞 Discover the principles of person-centered care: striving for healthcare that is more intuitive, transparent, and tailored to each individual. Explore our insights on how these practices could enhance patient outcomes and satisfaction. Read the full article: https://lnkd.in/diusDjTQ #HealthcareInnovation #PatientCare #DigitalHealth #Abdullatifjameelhealth #Jameelhealth

Could modality and administration route of BCMA-directed immunotherapies impact incidence and rate of CRS in patients with relapsed/refractory #MultipleMyeloma? Read our article to learn the latest data! https://loom.ly/xUEI2us #mmsm #myeloma #CRS

Diagnostics is broken. It’s too slow- It’s too reactive - And it’s costing lives. But here’s the shift happening right now. • The global diagnostics market is projected to reach $348 billion by 2030. • Point-of-care testing alone will be worth over $96 billion by 2028 • Respiratory diseases remain the third leading cause of death worldwide, with over 6 million lives lost annually. Yet, the way we diagnose diseases is still outdated. That is changing. • AI in healthcare diagnostics is set to grow to $9.6 billion by 2027. • AI-powered respiratory analysis has already achieved over 90 percent accuracy in detecting conditions like asthma and COPD. • More than 72 percent of patients now want access to at-home diagnostics, with over 60 percent willing to pay for convenience. The numbers are clear. Diagnostics isn’t just changing—it’s transforming. • Smarter diagnostics lead to better patient outcomes. • Faster detection lowers healthcare costs. • Proactive care creates a healthier future for all. Healthcare is moving forward. The question is, are we keeping up?

The prevalence of MASH continues to increase steadily on a global scale, underscoring the urgent need for therapeutic options for a diverse and growing patient population in MASH. While there is now an approved therapy, more therapeutic options are critically needed, including multiple modalities and potential combinations, for patients to have optimal treatment.   To learn more about our pipeline, visit: https://lnkd.in/guaY8Zz   #MASH #NASH #CardiometabolicDiseases  

👏 myBiometry secured a $5m investment in an oversubscribed seed funding round to propel the development of its fenoTRACK device for asthma and chronic obstructive pulmonary disease. The data obtained from the device is crucial in identifying patients at heightened risk of an exacerbation. myBiometry CEO Bryan Nolan shared: “With enhanced at-home monitoring for #asthma and COPD, we strive to identify attack risks sooner, enabling clinicians to offer more personalised care and preventive interventions that lessen the burden on patients, caregivers, and healthcare payers.” 🔗 Learn more: https://lnkd.in/dkX-XVBp 📰 Follow Guided Solutions to receive the latest #MedTech news daily and subscribe to our weekly newsletter: https://lnkd.in/djWx4ksY #MedicalDevices #MedicalEquipment #HealthTech #Headhunter #TalentManagement #GuidedSolutions #ExecutiveSearch #Executive #Csuite #MedTechExecutiveSearch #LungDisease

New Research Highlights the value of syndromic PCR testing for Vaginitis! At HealthTrackRx, we’re committed to advancing diagnostic solutions that improve patient outcomes while lowering healthcare costs. A recent study, co-authored by members of our team including Azia Lavrenyuk, PhD, Steve Goldberg, MD, MBA, Maren Fragala, PhD, CSCS.D, and Jay Reddy shows that syndromic multiplex RT-PCR testing with next-day results significantly reduces follow-up outpatient services and total healthcare costs compared to alternative PCR methods or no testing at all 6 months after diagnosis. This research demonstrates how rapid and accurate molecular diagnostics empower clinicians to deliver more targeted treatments, improving patient care while reducing the financial burden of unnecessary follow-ups. Read the full summary at the link below! https://bit.ly/40gP6Kt HealthTrackRx remains dedicated to driving innovation in diagnostics to benefit both patients and healthcare providers. #HealthTrackRx #Diagnostics #MolecularTesting #HealthcareInnovation #GettingPeopleHealthierFaster